Drug
Nn2802
Nn2802: highest development phase Phase 1/2, developed by Novelty Nobility, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Novelty Nobility, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| NN2802 NCT07930572 | Phase 1/2 | Healhty |
Latest
No recent events.
Follow Nn2802 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.